BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37899399)

  • 1. Neoadjuvant immune checkpoint inhibitor therapy and chemotherapy improve pulmonary ventilation and diffusion function in patients with lung cancer.
    Bao W; Zhou X; Gu F; Lin J; Li B
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 52(5):588-593. PubMed ID: 37899399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors.
    Yang H; Sun B; Ma W; Fan L; Xu K; Jia Y; Xu J; Wang Z; Yao F
    EBioMedicine; 2022 Oct; 84():104265. PubMed ID: 36116212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications.
    Cerfolio RJ; Talati A; Bryant AS
    Ann Thorac Surg; 2009 Sep; 88(3):930-5; discussion 935-6. PubMed ID: 19699923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?
    Leo F; Solli P; Spaggiari L; Veronesi G; de Braud F; Leon ME; Pastorino U
    Ann Thorac Surg; 2004 Jan; 77(1):260-5; discussion 265. PubMed ID: 14726074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of immune checkpoint inhibitors to treat non-small cell lung cancer patients harboring epidermal growth factor receptor mutations.
    Si J; Hao Y; Wei J; Xiang J; Xu C; Shen Q; Song Z
    BMC Pulm Med; 2023 May; 23(1):158. PubMed ID: 37147602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary ventilation function parameters of children aged 5-14 years in Kunming, China: a comparative analysis of measured values versus predicted values based on Zapletal equation].
    Yang J; Fu HM; Bai TZ; Wang F; Zhang O; Zhang SD; Nie WS
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Dec; 22(12):1313-1319. PubMed ID: 33328003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy.
    Tai H; Wang MY; Zhao YP; Li LB; Dong QY; Liu XG; Kuang JS
    Medicine (Baltimore); 2016 Aug; 95(33):e4541. PubMed ID: 27537577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Investigation of Pulmonary Function Changes of COVID-19 Patients in Three Months.
    Ye L; Yao G; Lin S; Fang Y; Chen X; Wang L; He S
    J Healthc Eng; 2022; 2022():9028835. PubMed ID: 35047158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is pulmonary function damaged by neoadjuvant lung cancer therapy? A comprehensive serial time-trend analysis of pulmonary function after induction radiochemotherapy plus surgery.
    Margaritora S; Cesario A; Cusumano G; Cafarotti S; Corbo GM; Ferri L; Ceppi M; Meacci E; Valente S; D'Angelillo RM; Russo P; Porziella V; Bonassi S; Pasqua F; Sterzi S; Granone P
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1457-63. PubMed ID: 20363001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer.
    Tfayli A; Al Assaad M; Fakhri G; Akel R; Atwi H; Ghanem H; El Karak F; Farhat F; Al Rabi K; Sfeir P; Youssef P; Mansour Z; Assi H; Haidar M; Abi Ghanem A; Khalifeh I; Boulos F; Mahfouz R; Youssef B; Zeidan Y; Bejjany R; Khuri F
    Cancer Med; 2020 Nov; 9(22):8406-8411. PubMed ID: 32991781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of pirfenidone combined with carboplatin-based chemotherapy in patients with idiopathic pulmonary fibrosis and non-small cell lung cancer: A retrospective cohort study.
    Yamamoto Y; Yano Y; Kuge T; Okabe F; Ishijima M; Uenami T; Kanazu M; Akazawa Y; Yamaguchi T; Mori M
    Thorac Cancer; 2020 Nov; 11(11):3317-3325. PubMed ID: 32986306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of the PD-1 Inhibitor Combined with Albumin-Bound Paclitaxel and Nedaplatin in Preoperative Neoadjuvant Therapy of Unresectable Stage III Lung Squamous Cell Carcinoma.
    Xu H; Wang W; Yin J; Song C; Li L; Sun Z
    Drug Des Devel Ther; 2022; 16():4269-4277. PubMed ID: 36540715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohesion between pulmonary artery and bronchus after immune checkpoint inhibitor therapy in a lung cancer patient.
    Takamori S; Takenoyama M; Matsubara T; Fujishita T; Ito K; Yamaguchi M; Toyozawa R; Seto T; Okamoto T
    Thorac Cancer; 2020 Dec; 11(12):3605-3608. PubMed ID: 33063937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total Lung and Lobar Quantitative Assessment Based on Paired Inspiratory-Expiratory Chest CT in Healthy Adults: Correlation with Pulmonary Ventilatory Function.
    Wu F; Chen L; Huang J; Fan W; Yang J; Zhang X; Jin Y; Yang F; Zheng C
    Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact and safety of adjuvant chemotherapy on pulmonary function in early stage non-small cell lung cancer.
    Kreuter M; Vansteenkiste J; Herth FJ; Fischer JR; Eberhardt W; Zuna I; Reinmuth N; Griesinger F; Thomas M;
    Respiration; 2014; 87(3):204-10. PubMed ID: 24192055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial and temporal heterogeneity of regional lung ventilation determined by electrical impedance tomography during pulmonary function testing.
    Vogt B; Pulletz S; Elke G; Zhao Z; Zabel P; Weiler N; Frerichs I
    J Appl Physiol (1985); 2012 Oct; 113(7):1154-61. PubMed ID: 22898553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvements in Lung Diffusion Capacity following Pulmonary Rehabilitation in COPD with and without Ventilation Inhomogeneity.
    Santus P; Radovanovic D; Balzano G; Pecchiari M; Raccanelli R; Sarno N; Di Marco F; Jones PW; Carone M
    Respiration; 2016; 92(5):295-307. PubMed ID: 27598467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of neoadjuvant immunotherapy on pulmonary function and perioperative outcomes in patients with resectable non-small cell lung cancer].
    Zhu Y; Li JQ; Chang Q; Qiang HP; Lu JH; Feng H; Shen YC; Qian JL; Chu TQ
    Zhonghua Yi Xue Za Zhi; 2022 Feb; 102(6):393-398. PubMed ID: 35144337
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary function changes following helical tomotherapy in patients with inoperable, locally advanced non-small cell lung cancer.
    Vekens K; Verbanck S; Collen C; Storme G; Barbé K; De Ridder M; Vanderhelst E
    Strahlenther Onkol; 2020 Feb; 196(2):142-150. PubMed ID: 31300831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.